Thermo Fisher Scientific Inc. (TN8.DE)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Marc N. Casper | Chairman, President & CEO | 6.87M | 67.83M | 1968 |
Mr. Stephen Williamson | Senior VP & CFO | 2.66M | 7.37M | 1967 |
Mr. Michel Lagarde | Executive VP & COO | 2.93M | 8.56M | 1975 |
Mr. Frederick M. Lowery | Executive VP and President of Laboratory Product & BioProduction | 2.05M | -- | 1971 |
Mr. Gianluca Pettiti | Executive VP and President of Life Science, Diagnostics & Applied | 2.36M | -- | 1979 |
Mr. Joseph R. Holmes | VP & Chief Accounting Officer | -- | -- | 1980 |
Mr. Ryan J. Snyder | Senior VP & Chief Information Officer | -- | -- | -- |
Dr. Karen E. Nelson Ph.D. | Chief Scientific Officer | -- | -- | -- |
Mr. Rafael Tejada | Vice President of Investor Relations | -- | -- | -- |
Mr. Michael A. Boxer Esq. | Senior VP & General Counsel | 1.55M | 2.56M | 1962 |
Thermo Fisher Scientific Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 125,000
Description
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Corporate Governance
Upcoming Events
July 22, 2025 at 12:30 PM UTC - July 28, 2025 at 12:30 PM UTC
Thermo Fisher Scientific Inc. Earnings Date
Recent Events
March 14, 2025 at 12:00 AM UTC
Ex-Dividend Date